Nepal, Sept. 18 -- Promoter stake sales in select companies have sparked interest, as they often signal strategic moves, diversification, or governance shifts. For investors, such actions may open opportunities while raising questions on long-term intent. Industry-wide, these developments highlight evolving ownership dynamics that can influence valuations, competitiveness, and future growth trajectories.
1. Natco Pharma
A drug manufacturer known for its presence in niche therapies. It produces formulations and APIs with a focus on affordable medicines. The company has a strong hold in oncology and other specialty segments.
With a market capitalisation of Rs. 15,758 crores, it rose to Rs. 884.40, hitting a high of up to 3.16 percent from...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.